Lene Holm Harritshoj

Lene Holm Harritshoj

Auto-generated profile, based on publicly available information

Lene Holm Harritshoj

Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2017 in Eurosurveillance
Verified
Journal Article
Open access
DDDragoslav Domanović
Dragoslav Domanović
RTRichard Tedder
Richard Tedder
JBJohannes Blümel
Johannes Blümel
HZHans Zaaijer
Hans Zaaijer
PGPierre Gallian
Pierre Gallian
PHPatricia Hewitt
Patricia Hewitt
The public health implications of hepatitis E virus (HEV) in Europe have changed due to increasing numbers of hepatitis E cases and recent reports of chronic, persistent HEV infections associated with progression to cirrhosis in immunosuppressed patients. The main infectious risk for such immunosuppressed patients is exposure to undercooked infected pork products and blood transfusion. We summarised the epidemiology of HEV infections among blood donors and also outlined any strategies to prevent transfusion-transmitted HEV, in 11 European countries. In response to the threat posed by HEV and related public and political concerns, most of the observed countries determined seroprevalence of HEV in donors and presence of HEV RNA in blood donations. France, Germany, Spain and the United Kingdom (UK) reported cases of transfusion-transmitted HEV. Ireland and the UK have already implemented HEV RNA screening of blood donations; the Netherlands will start in 2017. Germany and France perform screening for HEV RNA in several blood establishments or plasma donations intended for use in high-risk patients respectively and, with Switzerland, are considering implementing selective or universal screening nationwide. In Greece, Portugal, Italy and Spain, the blood authorities are evaluating the situation. Denmark decided not to implement the HEV screening of blood donations.

20 April 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
LHLene H. Harritshøj
Lene H. Harritshøj
MGMikkel Gybel-Brask
Mikkel Gybel-Brask
SAShoaib Afzal
Shoaib Afzal
PKPia R. Kamstrup
Pia R. Kamstrup
CJCharlotte S. Jørgensen
Charlotte S. Jørgensen
RDRam Benny Dessau
Ram Benny Dessau
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are needed to support clinical diagnosis and epidemiological investigations. Recently, assays for large-scale detection of total antibodies (Ab), immunoglobulin G (IgG), and IgM against SARS-CoV-2 antigens have been developed, but there are limited data on the diagnostic accuracy of these assays.

1 July 2010 in Journal of Hepatology
Verified
Journal Article
Closed access
LOLars Haukali Omland
Lars Haukali Omland
HKHenrik B. Bygum Krarup
Henrik B. Bygum Krarup
PJPeter Jepsen
Peter Jepsen
JGJørgen Georgsen
Jørgen Georgsen
LHLene Holm Harritshøj
Lene Holm Harritshøj
DSDANVIR Cohort Study
DANVIR Cohort Study

16 March 2014 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
LHLene Holm Harritshøj
Lene Holm Harritshøj
LHLene Holm
Lene Holm
CNConnie Nielsen
Connie Nielsen
HUHenrik Ullum
Henrik Ullum
MHMorten Bagge Hansen
Morten Bagge Hansen
HJHanne Olsen Julian
Hanne Olsen Julian

14 September 2007 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
Wolfram GerlichWolfram Gerlich
Wolfram Gerlich
FWFranz F. Wagner
Franz F. Wagner
MCMichael Chudy
Michael Chudy
LHLene Holm Harritshoj
Lene Holm Harritshoj
ALAnnette Lattermann
Annette Lattermann
EDEbbe Dickmeiss
Ebbe Dickmeiss

7 July 2016 in Transfusion
Verified
Journal Article
Closed access
PDF file
LHLene H. Harritshøj
Lene H. Harritshøj
DHDorte K. Holm
Dorte K. Holm
SSSusanne G. Sækmose
Susanne G. Sækmose
BJBitten A. Jensen
Bitten A. Jensen
BHBoris M. Hogema
Boris M. Hogema
HUHenrik Ullum
Henrik Ullum